Cresco Labs Inc. (OTCMKTS:CRLBF) Receives Consensus Rating of “Buy” from Analysts

Shares of Cresco Labs Inc. (OTCMKTS:CRLBF) have been assigned a consensus recommendation of “Buy” from the five ratings firms that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $3.00.

CRLBF has been the topic of a number of research analyst reports. Cormark raised shares of Cresco Labs from a “hold” rating to a “moderate buy” rating in a research report on Monday, March 17th. Atb Cap Markets cut shares of Cresco Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 9th.

Cresco Labs Stock Performance

OTCMKTS CRLBF opened at $0.73 on Friday. The company has a market capitalization of $356.34 million, a price-to-earnings ratio of -3.65 and a beta of 1.79. Cresco Labs has a twelve month low of $0.69 and a twelve month high of $2.60. The stock has a fifty day simple moving average of $0.86 and a 200 day simple moving average of $1.17. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80.

Cresco Labs (OTCMKTS:CRLBF) last posted its quarterly earnings data on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01). The business had revenue of $176.00 million during the quarter, compared to the consensus estimate of $172.10 million. Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. Sell-side analysts expect that Cresco Labs will post -0.2 EPS for the current year.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.